Targeted Medical Pharma, Inc. (TRGM)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 5, 2026
9,900%
Market Cap 2.95K
Revenue (ttm) 5.26M
Net Income (ttm) -3.04M
Shares Out 29.47M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 4,088
Open 0.0001
Previous Close n/a
Day's Range 0.0001 - 0.0246
52-Week Range 0.0000 - 0.0246
Beta -0.31
RSI n/a
Earnings Date n/a

About Targeted Medical Pharma

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyal... [Read more]

Sector Healthcare
Founded 1996
Employees 30
Stock Exchange OTCMKTS
Ticker Symbol TRGM
Full Company Profile

Financial Performance

In 2015, Targeted Medical Pharma's revenue was $5.26 million, a decrease of -26.03% compared to the previous year's $7.11 million. Losses were -$3.04 million, -21.85% less than in 2014.

Financial Statements

News

There is no news available yet.